Publication | Closed Access

Immunization with an HPV-16 L1-based chimeric virus-like particle containing HPV-16 E6 and E7 epitopes elicits long-lasting prophylactic and therapeutic efficacy in an HPV-16 tumor mice model

VaccinationHpv-16 E6Human Papillomavirus VaccinesImmunologyAntiviral ResponseTherapeutic EfficacyVirologyVaccine DesignImmunotherapyMedicineCancer-associated Virus